Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 1,561.39 +7.39 (0.48%)
price chart
A $7.8bn Reason To Buy GlaxoSmithKline plc Today
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) confirmed this morning that the three-part asset swap deal agreed with Novartis last year has completed.
GSK completes transaction with Novartis  The Times and Democrat
Should You Follow Neil Woodford And Buy GlaxoSmithKline plc, AstraZeneca ...
Neil Woodford has been an investor in the pharmaceuticals industry for most of his long career. In a recent blog, the ace fund manager wrote: "The pharmaceuticals sector is no longer as cheap as it was but it still looks very attractive in my view ...
GlaxoSmithKline plc And SkyePharma PLC: A Match Made In Heaven?
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is a great stock for any portfolio. Indeed, the company has all the best qualities you could ask for - a high dividend yield, attractive valuation healthy balance sheet, dominant market position and a reliable ...
The Benefits Of Investing In GlaxoSmithKline plc
With economic growth in developing regions and thus investment in domestic healthcare continuing to power higher, demand for GlaxoSmithKline's suite of market-leading products is likely to keep on rising. Indeed, the pharmaceutical-play saw emerging ...
It's Official! Vodafone Group plc, GlaxoSmithKline plc & Imperial Tobacco ...
Every year, the top City analysts produce a chart outlining the best dividend yields on offer in the developed markets consumer goods sector.
3 Reasons Why GlaxoSmithKline plc And AstraZeneca plc Are Worth Buying ...
US) did not come off last year, both it and sector peer GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) could prove to be realistic bid targets moving forward.
GlaxoSmithKline plc (GSK) Continues To Be One Of The Most Attractive Pharma ...  InvestCorrectly
GlaxoSmithKline plc To Go Ex-Dividend on February 18th (GSK)  The Legacy
Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or ...
If you're struggling to choose between GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN), you're not alone.
Why GlaxoSmithKline plc's Dividend Yield Will Top 11% This Year!
Last year, GlaxoSmithKline (LSE :GSK) and peer Novartis unveiled a complex three-way deal in which the two pharmaceutical giants would trade more than �11bn of assets.
Glaxo Posts Sharp Fall in Profit  Wall Street Journal
UPDATE: Glaxo Pretax Profit Down, Confirms GBP4 Billion Cash Return  London South East
Baader Helvea Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �hold� rating restated by investment analysts at Baader Helvea in a note issued to investors on Monday.
3 Reasons I Believe GlaxoSmithKline plc Is One Step Ahead Of AstraZeneca plc
Today, it's a different picture: much of AstraZeneca's likely future recovery has now been priced into the stock, and the Anglo-Swedish firm's shares trade on a more demanding rating of 16.1 times 2015 forecast earnings.